New pill aims to stop Chemotherapy's dangerous blood side effect
NCT ID NCT07492693
Summary
This study is testing if a drug called hetrombopag can safely prevent a dangerous drop in platelets (cells that help blood clot) caused by chemotherapy in people with stomach, colon, or other gastrointestinal cancers. It will enroll 40 patients who are at risk for this side effect. Participants will take the pill daily for 14 days during their chemo cycle to see if it keeps their platelet counts high enough to avoid treatment delays or transfusions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) IN PATIENTS WITH GASTROINTESTINAL TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Changhai Hospital
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.